SCANSOURCE, INC. (SCSC) stock intrinsic value fair value estimate & owner earnings analysis

ScanSource is a specialty technology distributor. It buys point-of-sale terminals, barcode scanners and printers, payment devices, and communications and networking equipment from manufacturers such as Cisco and Zebra Technologies and resells them, with services attached, to about tens of thousands of resellers and solution providers in the United States, Canada and Brazil. Its second business, Intelisys & Advisory, acts as a master agent: it connects resellers with cloud, connectivity and cybersecurity service providers and earns recurring commissions on those contracts. In fiscal 2026 (year ended June 30, 2026) sales were $3.23 billion, about 93% in the United States; Intelisys & Advisory produced only about $101 million of sales but nearly $100 million of gross profit, close to a quarter of the company's total. Products from Cisco and Zebra each made up more than 10% of sales, under non-exclusive agreements that renew year to year and can be ended on short notice. We measure the business from fiscal 2020, when ScanSource sold its Europe, UK, Mexico, Colombia, Chile and Peru distribution operations; earlier results describe a larger, different company. Distribution cash flow swings wildly with inventory: operating cash flow was negative in fiscal 2022 and 2023 as the company stocked up during the component shortage, then jumped to $372 million in fiscal 2024 as that inventory sold through. We remove those working-capital swings and charge stock compensation as a real cost. Capital spending is tiny, about a quarter of a percent of sales. Amortization of acquired customer relationships (about $17 million in fiscal 2026) is added back as a sunk acquisition cost; because those relationships wear out, we give the business no organic growth credit in the base case to carry that decay. On that basis the business, before paying its lenders, has produced between about $102 million and $128 million of cash a year in fiscal 2022 through 2026, with a typical (median) year of about $113 million. Owners actually received roughly $106 million in fiscal 2026 after about $6 million of interest. That is the level we start from. Fiscal 2026 was flat on fiscal 2025 (cash before lenders about $112 million versus $113 million), so the base case starts year one slightly below the typical level and then holds it flat. What changed since our last look: ScanSource has since borrowed about $220 million under its bank facility to buy MicroAge, a U.S. IT solutions integrator and managed services provider with about 2,400 clients, and the deal closed in September 2026. The company has published no revenue or profit figures for MicroAge, so we credit no earnings from it; we carry it at what was paid in the base and bull cases and at half that in the bear case, reflecting the company's own record of overpaying, including about $120 million of impairments in fiscal 2020. Underlying cash generation, which we previously flagged as drifting down, held level in fiscal 2026, and the share count kept falling, to about 20.2 million shares outstanding at June 30, 2026 from 22.2 million a year earlier. Debt: at June 30, 2026 ScanSource owed about $101 million (a $98.8 million term loan and a small Mississippi industrial bond), with its revolving credit line and term loan maturing December 18, 2030. Adding the roughly $220 million drawn for MicroAge and crediting about $50 million of the $88 million cash balance as more than the business needs to operate, net debt is about $272 million, or roughly $13 per share. The term loan's rate (4.65% at year end) is close enough to a normal long-term rate that we make no adjustment. Interest on the enlarged debt is roughly $15 to $20 million a year, comfortably covered in every case. Base case: hardware distribution keeps growing roughly with its vendors and Intelisys keeps its recurring commission base (net billings grew 3.2% to $2.88 billion in fiscal 2026), but we credit no growth, because neither share gains nor the hoped-for benefits of MicroAge are yet earned. The business is worth about $2.10 billion including MicroAge at cost; less about $272 million of net debt leaves about $1.83 billion, or about $88 per share. Bear case: one full downturn of the kind this business has actually had. In fiscal 2024 sales fell 14% and cash before lenders dropped to about $102 million; in fiscal 2020 the pandemic and the European exit produced a goodwill write-off and a loss. We model cash before lenders falling about 25% for two years, recovering to only about 88% of today's typical level as vendors such as Cisco and Zebra push more volume direct or through cloud marketplaces and carriers squeeze agent commissions, and then slowly shrinking by 2% a year. MicroAge is carried at half its price. The business is worth about $1.50 billion, less $272 million of net debt, or about $59 per share. Even at the trough the business covers its interest several times over, so the debt does not threaten the shares in this case. Bull case: the business's own levers keep working: Intelisys's recurring commissions, a growing services and managed-services mix, and the long-run pace of small tuck-in acquisitions lift cash before lenders about 2% a year for ten years and hold there. That is at the low end of what the company has demonstrated and does not assume any boost from MicroAge beyond what was paid. The business is worth about $2.42 billion, less $272 million of net debt, or about $104 per share. After year ten in the base and bull cases we hold earnings flat rather than growing them: a broadline vendor-to-reseller distribution and agency network is a durable structure, but nothing we can point to makes it grow on its own. That long tail is a large share of each value, so a reader should know the case rests on ScanSource still being a needed middleman a decade from now. Margin-of-safety price. We are fairly confident in the earnings level: five years since the divestiture, through a shortage, a glut and an inventory unwind, cash before lenders stayed between about $100 million and $128 million. The worst plausible event that no case fully models is the loss or rewriting of the Cisco or Zebra agreements, each over 10% of sales and cancellable on short notice; the business would survive it, because debt is modest, the assets are mostly receivables and inventory that turn into cash as the business shrinks, and Intelisys's commissions do not depend on either vendor, but it would leave a business valued well below the bear case. The things we are most likely to be wrong about are what MicroAge actually earns and whether hardware distribution margins hold; if MicroAge proves worth half its price and hardware margins slip, the shares are worth roughly the high $60s to low $70s. ScanSource pays no dividend; instead it has been spending around $100 million a year buying back stock, roughly its whole free cash, which concentrates value for remaining holders. The price assumes a three-to-five-year holding period. At $60 per share the price is about the bear-case value, the buybacks alone would retire around 8% of the company a year at that price, and reasonable progress toward the median outcome implies the required return; above that the estimate relies on the base case going right. The margin-of-safety price is $60. The figures for fiscal 2018 and 2019 used here come from the restated continuing-operations cash flow published in the fiscal 2020 annual report; they are shown for history only and are not used to set the earnings level.